SCHEMBL1583000

SCHEMBL1583000

CC(C)(C)c1ccc(C(=O)C2CCN(CC(OC(N)=O)c3ccccc3Cl)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.51
KMT2A Q03164 7/20 0.51
POLB P06746 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MGLL Q99685 2/20 0.39
HRH2 P25021 2/20 0.38
HRH1 P35367 2/20 0.38
NPC1 O15118 1/20 0.38
MLNR O43193 1/20 0.38
NR1I2 O75469 1/20 0.38
EGFR P00533 1/20 0.38
LMNA P02545 1/20 0.38
ERBB2 P04626 1/20 0.38
FYN P06241 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
ABCB1 P08183 1/20 0.38
ADRB1 P08588 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1582811 0.89 MGLL (0.50) MEN1KMT2AMGLLLMNAKCNH2
SCHEMBL1582754 0.89 HTR2A (0.47) MEN1KMT2APOLBMGLLLMNA
SCHEMBL1583136 0.87 MGLL (0.51) MEN1KMT2APOLBALDH1A1SMN1; SMN2
SCHEMBL1582914 0.87 POLB (0.53) POLBSMN1; SMN2MGLLLMNAHTR2A
SCHEMBL1582751 0.82 HSD11B1 (0.47) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6470699 0.79 MEN1 (0.51) MEN1KMT2APOLBALDH1A1MGLL
SCHEMBL1582920 0.78 HSD11B1 (0.51) MEN1KMT2ASMN1; SMN2LMNAHTR2A
SCHEMBL1582768 0.77 HSD11B1 (0.50) POLBSMN1; SMN2MGLLLMNAHTR2A
SCHEMBL6007451 0.74 MEN1 (0.57) MEN1KMT2ASLC6A2HTR2ASLC6A4
SCHEMBL1582856 0.74 HSD11B1 (0.54) SMN1; SMN2LMNAHTR2AHTR2CHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546100-B1 NEW BENZOYL PIPERIDINE COMPOUNDS SK HOLDINGS CO LTD (KR) 2011-04-20 EP disclosed
EP-1546100-B1 NEW BENZOYL PIPERIDINE COMPOUNDS SK HOLDINGS CO LTD (KR) 2011-04-20 EP disclosed
US-6770659-B2 Benzoyl piperidine compounds SK CORPORATION (KR) 2004-08-03 US disclosed
WO-2004018423-A1 NEW BENZOYL PIPERIDINE COMPOUNDS SK CORPORATION (KR) 2004-03-04 WO disclosed
US-20040044033-A1 New benzoyl piperidine compounds SK BIOPHARMACEUTICALS CO., LTD. (KR) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044033-A1 New benzoyl piperidine compounds GABRE, GRIN2C, GRIN1 MEN1 3741/4885KMT2A 1518/4885POLB 2444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.